Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
The primary operational upside catalyst is accelerating market penetration in liquid cooling systems for AI data centers and complex industrial wastewater recycling.
Consolidated operating margin falling below 10.54% (a 300 bps contraction from the FY2025 baseline of 13.54%).
Xylem Inc. (NYSE: XYL) is rated Reduce with an intrinsic fair value of $90.73 per share, representing an implied return of -11.5% against the market price of $102.53 as of October 7, 2026. While Xylem commands a defensible municipal utility moat and benefits from rapid growth in AI data center cooling (~200% growth in FY2026), current trading multiples at 17.4x forward earnings price in near-flawless execution while understating persistent installation delays in smart electric metering and a 30% order contraction across China.45
Xylem Inc. represents a high-quality water technology franchise operating across water transport, treatment, and digital metering. In FY2025, the company generated $9,035,000,000 in revenue with an of 13.54% ($1,223,000,000 ) and delivered of $3.92. reached $1,241,000,000 against of $331,000,000, yielding of $910,000,000. However, at the October 7, 2026 share price of $102.53, the equity trades at a 13.0% premium above our intrinsic midpoint of $90.73.
The operational thesis reflects diverging cross-currents across business units. In Water Infrastructure and Water Solutions and Services, municipal spending and industrial wastewater reuse remain healthy. Data center cooling solutions are guided to expand ~200% in FY2026, exiting the year at approximately 2% of total company sales. Conversely, Measurement & Control Solutions experienced book-to-bill below 1.0 in Q2 2026 due to electric utility deployment delays, and Asia-Pacific operations faced a 30% contraction in orders and revenue stemming from Chinese infrastructure reallocations.5
Balance sheet leverage is manageable, with total debt of $3,055,000,064 against annual operating cash flows of $1,241,000,000. To protect delivery schedules, management proactively maintains strategic buffer inventories of approximately 12 months for critical rare earths and 6 months for chips and wafers. While these buffers prevent manufacturing halts, they necessitate working capital absorption of 18% to 22% of NOPAT, limiting rapid free cash flow acceleration during project deferral periods.257
Our synthesized fair value of $90.73 is anchored primarily on forward earnings capitalization ($89.19 midpoint, 30% weight) and discounted earnings ($99.67 midpoint, 25% weight) using a moderate cost of equity of 9.36% and enterprise WACC of 8.84%. Sell-side consensus indicates a 12-month forward price target mean of $151.31 ($138.36 present-value equivalent discounted at 9.36%), reflecting broader optimism regarding long-term municipal outlays. Our valuation models project disciplined organic growth of 2.2% to 5.2% and steady margin expansion toward 15.6%, showing that current prices offer an unfavorable risk/reward skew and supporting a Reduce recommendation.27
Xylem's data center cooling revenue is projected to expand approximately 200% in FY2026, reaching roughly 2% of company sales by year end. Rapid liquid cooling adoption across AI compute infrastructure provides a high-margin secular growth vector.5
Water Infrastructure generated $2,636,000,000 in FY2025 revenue and $462,000,000 in operating income. Municipal clean water mandates and severe failure costs create high switching costs and dependable recurring aftermarket revenue.8
Disciplined 80/20 commercial execution and synergy capture from the Evoqua integration are structured to lift operating margins from 13.54% in FY2025 to 15.58% by FY2030, reinforcing free cash flow generation ($910,000,000 in FY2025).567
We assign Xylem Inc. a Reduce rating based on an intrinsic fair value of $90.73 per share versus the share price of $102.53 as of October 7, 2026. Trading at a 13.0% premium to intrinsic value and 17.4x forward earnings, valuation levels leave an insufficient margin of safety against ongoing smart metering project delays and regional industrial softness in Asia-Pacific.45
Xylem Inc. is a global water technology provider engaged in the design, manufacture, and servicing of engineered solutions across the water lifecycle. The company operates through four primary segments: Water Infrastructure, Water Solutions and Services, Measurement & Control Solutions, and Applied Water. In FY2025, consolidated revenue reached $9,035,000,000, generating operating income of $1,223,000,000 and free cash flow of $910,000,000.
Water Infrastructure delivered $2,636,000,000 in FY2025 revenue and $462,000,000 in operating income, supplying clean water pumps, wastewater transport, and secondary treatment equipment to municipal and industrial customers. Water Solutions and Services contributed $2,464,000,000 in FY2025 revenue and $302,000,000 in operating income, providing industrial water purification, remediation, and mobile fleet services bolstered by the Evoqua integration.
Measurement & Control Solutions generated $2,086,000,000 in FY2025 revenue and $244,000,000 in operating income, offering smart metering infrastructure, sensors, and network analytics for water, gas, and electric utilities. Applied Water generated $1,849,000,000 in FY2025 revenue and $312,000,000 in operating income, serving commercial building, residential, and industrial applications. Geographically, the United States represented $5,209,000,000 of FY2025 revenue, Europe $1,839,000,000, Asia-Pacific $1,221,000,000, and other international markets $766,000,000.
A severe macroeconomic and operational stress test models a simultaneous deterioration across Xylem's core growth and margin drivers. In this scenario, prolonged customer-side installation bottlenecks in smart electric metering cause Measurement & Control Solutions book-to-bill to remain depressed below 0.95, while the 30% contraction observed in China infrastructure spending spreads into European commercial building construction. As high-margin volume softens, unabsorbed overhead from 80/20 product line pruning and raw material cost inflation force consolidated operating margins down by 300 basis points from FY2025 baseline levels of 13.54% to 10.54%. In parallel, maintaining strategic buffer inventories (12 months of rare earths, 6 months of chips) increases working capital absorption during top-line deceleration, constraining free cash flow generation. When evaluated under peer cyclical valuation multiples where the forward P/E compresses from the current 17.39x down toward peer engine and machinery levels of 13.6x, enterprise fair value compresses toward the low-end boundary of $80.29. This stress test underscores that current market pricing at $102.53 offers inadequate downside protection against operational execution slippage.
XYL baseline FY2025 EBIT margin was 13.54% on $1,223,000,000 operating income. If persistent raw material inflation and 30% order contractions in China spread to European Applied Water, consolidated operating margins falling below 10.54% would reduce annual operating income by ~$275M, impairing enterprise fair value by over 20%.57
De vijf ontwikkelingen die onze beleggingsthese zouden verzwakken.
Signals persistent installation deferrals in smart electric metering, which depletes the $1.2 billion segment backlog and threatens consolidated revenue realization.
Huidig:< 1.0 (Q2 2026)
Waarschuwing als< 0.95 for two consecutive quarters
Xylem Inc. commands an enduring narrow economic moat rooted in high customer switching costs, regulatory compliance barriers, and an extensive municipal installed base. In municipal water transport, treatment, and wastewater conveyance, equipment failure carries catastrophic health, environmental, and financial liabilities. Consequently, municipal utility operators avoid replacing proven pump and treatment systems with untested alternatives, locking in Xylem's equipment across multi-decade lifecycle contracts. In FY2025, Water Infrastructure delivered $2,636,000,000 in revenue and $462,000,000 in operating income, while Water Solutions and Services contributed $2,464,000,000 in revenue and $302,000,000 in operating income. This combined scale establishes a highly defensible platform generating consistent aftermarket parts, consumables, and maintenance revenue.
The durability of Xylem's competitive position is further augmented by its specialized fluid engineering and digital metering technologies. Through its Measurement & Control Solutions segment ($2,086,000,000 in FY2025 revenue), Xylem integrates smart sensors, advanced acoustic leak detection, and smart water meters into utility grid management software. Furthermore, the combination with Evoqua expanded capabilities into critical high-tech industrial verticals, including semiconductor ultrapure water, lithium-ion battery manufacturing, and AI data center liquid cooling loops—where data center revenue is guided to surge ~200% in FY2026. These specialized industrial treatment niches prevent commoditization and enable Xylem to generate gross margins of 38.46%, comfortably surpassing broader industrial machinery peers like Cummins (25.77%).
While Xylem's economic moat is robust, it is rated Narrow rather than Wide due to the capital intensity of large acquisitions and cyclical vulnerabilities in certain regional end markets. The acquisition of Evoqua resulted in $8,332,000,000 in goodwill, which temporarily suppresses balance-sheet return on invested capital to 8.18%, slightly below the computed WACC of 8.84%. In addition, international public infrastructure exposure introduces cyclical volatility, as demonstrated by the ~30% decline in second-quarter orders and sales in China. Nevertheless, proactive supply chain buffering—holding 12 months of rare earths and 6 months of chips —and disciplined 80/20 portfolio optimization safeguard operational execution and underpin a stable narrow economic moat.
Economic profit generation displays structural resilience despite accounting-basis dilution following large-scale portfolio acquisitions. Latest reported ROIC of 8.18% sits slightly below the computed WACC of 8.84%, driven by the substantial goodwill balance of $8,332,000,000 recognized in the Evoqua combination. However, cash flow generation and operating profitability remain robust: FY2025 operating income was $1,223,000,000, operating cash flow reached $1,241,000,000, and free cash flow generated was $910,000,000. As synergy capture matures and 80/20 portfolio optimization lifts operating margins toward 15.58% by FY2030, operating is projected to steadily exceed the 8.84% cost of capital.
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
The highlighted cell is Fair value when every assumption sits at its base level ($90.73). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $866.5M after modeled reinvestment of $190.2M, with terminal value at 75.8% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
In the base scenario, consolidated revenue expands at a moderate pace from $9,035,000,000 in FY2025 toward consensus FY2027 revenue of $9,620,179,580. Operating margins expand from 13.97% in FY2026 to 15.58% by FY2030, driven by operational productivity and 80/20 portfolio optimization. Applying a 9.36% cost of equity and a 17.0x terminal multiple yields an intrinsic fair value of $90.73.1257
An earnings beat driven by faster-than-expected recovery in smart electric metering and sustained double-digit water order momentum would alleviate near-term top-line headwinds and narrow the valuation gap.
Meeting guidance confirms that operational execution and commercial productivity gains remain on track, but valuation relative to Fair value at $90.73 already fully reflects these gains.
A miss triggered by worsening project deferrals in electric metering or further deterioration in European and Chinese markets would confirm structural top-line drag and compress operating margins below guidance targets.
Xylem's earnings quality is characterized by strong operating cash conversion, transparent non-GAAP reconciliations, and low reliance on accounting accruals. In FY2025, GAAP diluted EPS was $3.92 on GAAP net income of $957,000,000, while operating cash flow reached $1,241,000,000 and free cash flow generated was $910,000,000. The high cash conversion ratio—operating cash flow significantly exceeding GAAP net income—demonstrates that reported earnings power is fully backed by realized cash inflows. Management's raised full-year 2026 adjusted EPS guidance of $5.55 to $5.70 reflects standard adjustments for intangible asset amortization from the Evoqua acquisition and routine restructuring costs. Operating remains well managed despite strategic inventory investments (12 months of rare earths, 6 months of chips), and of $331,000,000 remain disciplined relative to sales, confirming robust earnings durability.
Consensus earnings estimates exhibit positive post-event momentum following the Q2 2026 earnings release. Sell-side consensus raised FY2026 diluted EPS estimates by 0.59% from $5.54 to $5.66 and reiterated FY2027 EPS consensus at $6.23. Full-year 2026 consensus revenue was slightly calibrated downward by 0.09% to $9,203,139,620 to reflect smart electric metering project installation delays, but FY2027 consensus revenue was nudged upward to $9,620,179,580. Upward estimate momentum is driven by management raising full-year adjusted EPS guidance to $5.55-$5.70 and guiding to 90-130 bps of full-year operating margin expansion.15
Xylem generates exceptional operating and free cash flows characterized by high cash conversion. In FY2025, operating cash flow was $1,241,000,000 and capital expenditures were $331,000,000, yielding free cash flow of $910,000,000. Free cash flow conversion stood at 95.1% of GAAP net income ($957,000,000). Management targets a low-double-digit free cash flow margin for full-year 2026. Working capital requirements remain well absorbed, even as management maintains strategic buffer inventory (12 months of rare earths, 6 months of chips), providing predictable liquidity to fund operational growth.5
Xylem's ROIC trajectory is projected to improve as merger integration synergies from Evoqua materialize and 80/20 commercial execution eliminates low-margin product walkaway. While the recognition of $8,332,000,000 in goodwill expanded the invested capital base and suppressed latest accounting ROIC to 8.18%, the structural improvement in operating margins from 13.54% in FY2025 to 15.58% by FY2030 will expand NOPAT from $1,056,668,573 in FY2026 to $1,417,787,609 in FY2030. Modest reinvestment rates of 18-22% of NOPAT ensure capital discipline, steadily expanding cash returns on tangible capital.
Latest reported ROIC of 8.18% sits slightly below the computed WACC of 8.84% due to acquisition goodwill, but returns on tangible invested capital remain well above cost of capital and operating margin expansion is projected to drive ROIC above WACC over the forecast horizon.
| Omzet | US$ 2.336.000.000 |
|---|---|
| Kostprijs van de omzet | US$ 1.373.000.000 |
| Brutowinst | US$ 963.000.000 |
| Bedrijfskosten | US$ 573.000.000 |
| Bedrijfsresultaat | US$ 390.000.000 |
| Niet-operationele posten en belastingen | US$ -127.000.000 |
| Nettowinst | US$ 263.000.000 |
| Totale activa | US$ 16.112.000.000 |
|---|---|
| Liquide middelen | US$ 1.019.000.000 |
| Vlottende activa | US$ 3.884.000.000 |
| Totale verplichtingen | US$ 5.936.000.000 |
| Kortlopende verplichtingen | US$ 2.205.000.000 |
| Eigen vermogen | US$ 10.176.000.000 |
| Nettowinst | US$ 957.000.000 |
|---|---|
| Operationele instroom | US$ 1.585.000.000 |
| Afschrijvingen en amortisatie | US$ 575.000.000 |
| Aandelenbeloning | US$ 53.000.000 |
| Operationele kasstroom | US$ 1.241.000.000 |
| Operationele uitstroom | US$ 344.000.000 |
| Beschikbare liquide middelen | US$ 2.452.000.000 |
| Beginstand liquide middelen | US$ 1.121.000.000 |
| Wisselkoerseffect | US$ 90.000.000 |
| Investeringsuitstroom | US$ 471.000.000 |
| Investeringen | US$ 331.000.000 |
| Overige investeringsactiviteiten | US$ 140.000.000 |
| Financieringsuitstroom | US$ 501.000.000 |
| Aandeleninkoop | US$ 15.000.000 |
| Betaalde dividenden | US$ 391.000.000 |
| Netto schuldaflossing | US$ 81.000.000 |
| Overige financieringsactiviteiten | US$ 14.000.000 |
| Eindstand liquide middelen | US$ 1.479.000.000 |
| Investeringskasstroom | US$ -471.000.000 |
| Financieringskasstroom | US$ -501.000.000 |
Bron: SEC EDGAR · Ingediend 2026-02-25 · SEC EDGAR
| Omzet per operationeel segment | Omzet | Aandeel | j-o-j |
|---|---|---|---|
| Water Infrastructure | US$ 2,6 mld. | 29,2% | 3,2% |
| Water Solutions Services | US$ 2,5 mld. | 27,3% | 5,2% |
| Measurementand Control Solutions | US$ 2,1 mld. | 23,1% | 11,5% |
| Applied Water | US$ 1,8 mld. | 20,5% | 3,1% |
Bron: SEC EDGAR · Ingediend 2026-02-25 · SEC EDGAR
| Omzet per regio | Omzet | Aandeel | j-o-j |
|---|---|---|---|
| United States | US$ 5,2 mld. | 57,7% | 7,1% |
| Europe | US$ 1,8 mld. | 20,4% | 5,4% |
| Asia Pacific | US$ 1,2 mld. | 13,5% | -4,2% |
| Other | US$ 766 mln. | 8,5% | 12,5% |
Financiële momentopname gebruikt in de analyse van 2026-10-07.
| Periode | Omzet | EBITDA | Nettowinst | Operationele kasstroom | Vrije kasstroom | Investeringen | Afschrijvingen en amortisatie | Aandelenbeloning | Aandeleninkoop | Betaalde dividenden | Netto schuldemissie | Investeringskasstroom | Financieringskasstroom | Beginstand liquide middelen | Eindstand liquide middelen | Kas en beleggingen | Totale schuld | Operationele marge | ROIC | WACC | ROIC−WACC-spread |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | US$ 3,8 mld. | US$ 561 mln. | US$ 260 mln. | US$ 497 mln. | US$ 373 mln. | US$ 124 mln. | US$ 151 mln. | US$ 18 mln. | US$ 4 mln. | US$ 112 mln. | — | -US$ 1,9 mld. | US$ 1 mld. | — | US$ 308 mln. | US$ 308 mln. | US$ 2,5 mld. | 10,8% | — | 5,9% | — |
| 2017-12-31 | US$ 4,7 mld. | US$ 782 mln. | US$ 331 mln. | US$ 686 mln. | US$ 516 mln. | US$ 170 mln. | US$ 234 mln. | US$ 21 mln. | US$ 25 mln. | US$ 130 mln. | — | -US$ 181 mln. | -US$ 421 mln. | US$ 308 mln. | US$ 414 mln. | US$ 414 mln. | US$ 2,2 mld. | 11,7% | — | 6,1% | — |
| 2018-12-31 | US$ 5,2 mld. | US$ 928 mln. | US$ 549 mln. | US$ 586 mln. | US$ 349 mln. | US$ 237 mln. | US$ 261 mln. | US$ 30 mln. | US$ 59 mln. | US$ 152 mln. | — | -US$ 643 mln. | -US$ 40 mln. | US$ 414 mln. | US$ 296 mln. | US$ 296 mln. | US$ 2,3 mld. | 12,6% | — | 6,9% | — |
| 2019-12-31 | US$ 5,2 mld. | US$ 740 mln. | US$ 401 mln. | US$ 839 mln. | US$ 613 mln. | US$ 226 mln. | US$ 257 mln. | US$ 29 mln. | US$ 40 mln. | US$ 174 mln. | — | -US$ 231 mln. | -US$ 177 mln. | US$ 296 mln. | US$ 724 mln. | US$ 724 mln. | US$ 2,4 mld. | 9,3% | — | 6,0% | — |
| 2020-12-31 | US$ 4,9 mld. | US$ 613 mln. | US$ 254 mln. | US$ 824 mln. | US$ 641 mln. | US$ 183 mln. | US$ 251 mln. | US$ 26 mln. | US$ 61 mln. | US$ 188 mln. | — | -US$ 169 mln. | US$ 473 mln. | US$ 724 mln. | US$ 1,9 mld. | US$ 1,9 mld. | US$ 3,1 mld. | 7,5% | — | 4,7% | — |
| 2021-12-31 | US$ 5,2 mld. | US$ 832 mln. | US$ 427 mln. | US$ 538 mln. | US$ 330 mln. | US$ 208 mln. | US$ 245 mln. | US$ 33 mln. | US$ 68 mln. | US$ 203 mln. | — | -US$ 183 mln. | -US$ 855 mln. | US$ 1,9 mld. | US$ 1,3 mld. | US$ 1,3 mld. | US$ 2,5 mld. | 11,3% | — | 5,5% | — |
| 2022-12-31 | US$ 5,5 mld. | US$ 726 mln. | US$ 355 mln. | US$ 596 mln. | US$ 388 mln. | US$ 208 mln. | US$ 236 mln. | US$ 37 mln. | US$ 52 mln. | US$ 217 mln. | -US$ 527 mln. | -US$ 191 mln. | -US$ 790 mln. | US$ 1,3 mld. | US$ 944 mln. | US$ 944 mln. | US$ 1,9 mld. | 11,3% | — | 7,9% | — |
| 2023-12-31 | US$ 7,4 mld. | US$ 1,1 mld. | US$ 609 mln. | US$ 837 mln. | US$ 566 mln. | US$ 271 mln. | US$ 436 mln. | US$ 60 mln. | US$ 25 mln. | US$ 299 mln. | US$ 118 mln. | -US$ 628 mln. | -US$ 157 mln. | US$ 944 mln. | US$ 1 mld. | US$ 1 mld. | US$ 2,4 mld. | 8,9% | — | 7,9% | — |
| 2024-12-31 | US$ 8,6 mld. | US$ 1,7 mld. | US$ 890 mln. | US$ 1,3 mld. | US$ 942 mln. | US$ 321 mln. | US$ 562 mln. | US$ 56 mln. | US$ 20 mln. | US$ 350 mln. | -US$ 284 mln. | -US$ 482 mln. | -US$ 615 mln. | US$ 1 mld. | US$ 1,1 mld. | US$ 1,1 mld. | US$ 2 mld. | 11,8% | — | 8,4% | — |
| 2025-12-31 | US$ 9 mld. | US$ 1,8 mld. | US$ 957 mln. | US$ 1,2 mld. | US$ 910 mln. | US$ 331 mln. | US$ 575 mln. | US$ 53 mln. | US$ 15 mln. | US$ 391 mln. | -US$ 81 mln. | -US$ 471 mln. | -US$ 501 mln. | US$ 1,1 mld. | US$ 1,5 mld. | US$ 1,5 mld. | US$ 2 mld. | 13,5% | — | 8,4% | — |
Xylem Inc. (XYL) trades at 17.4x forward earnings against a peer median of 16.5x. Its EV/EBITDA of 13.4x compares with a peer median of 16.3x. The comparison uses 4 peers: Dover Corporation, Ingersoll Rand Inc., Cummins Inc. and Generac Holdings Inc., as of 2026-10-06 to 2026-10-07.
Broader industrial peer and sector benchmarks show an industry capex-to-revenue ratio of 4.10% and an industry capex-to-depreciation ratio of 0.68, indicating that sector participants are reinvesting capital at levels below annual asset depreciation. For Xylem, FY2025 capex was $331,000,000 against $9,035,000,000 of revenue (3.66% capex-to-revenue) and D&A was $575,000,000, resulting in a capex-to-depreciation ratio of 0.58. Because industry-wide supplier capacity additions, lead-times, and customer concentration metrics are not tracked in reporting benchmarks, this cycle evaluation is demand-led and evidence-limited.7
In a cyclical upswing, municipal utilities accelerate federal infrastructure funding disbursements to replace aging water transport mains, rehabilitate treatment plants, and mandate smart water and electric metering upgrades. Simultaneously, high-growth industrial sectors ramp capital spending into water-intensive processes, driving triple-digit growth in AI data center liquid cooling loops (~200% growth in FY2026) and advanced water circularity systems for semiconductor and lithium battery manufacturing. Operating leverage from 80/20 commercial execution and synergy capture unlocks over 100 bps of annual operating margin expansion, pushing cash conversion above 100%.
In a cyclical downturn, municipal utilities defer non-essential water network upgrades, delay advanced metering infrastructure rollouts, and freeze capital allocations. Compounding this risk, regional infrastructure spending in emerging markets like China contracts sharply, as evidenced by a 30% contraction in Q2 orders and sales, while European commercial construction bumps along sluggishly. Concurrently, persistent utility customer installation delays reduce book-to-bill below 1.0, compressing operating margins and stranding working capital in buffer inventory.
Xylem is positioned as the premier pure-play global water technology provider, possessing unmatched breadth across water conveyance, biological treatment, and digital smart metering. With $9,035,000,000 in FY2025 revenue distributed across Water Infrastructure (29.2%), Water Solutions and Services (27.3%), Measurement & Control Solutions (23.1%), and Applied Water (20.5%), Xylem balances regulated, defensive municipal utility demand with high-growth, high-margin industrial applications. Its extensive geographical presence—generating $5,209,000,000 in the U.S., $1,839,000,000 in Europe, and $1,221,000,000 in Asia-Pacific —insulates the group from regional recessions, while its proactive 80/20 portfolio optimization aligns resources with fast-growing secular end markets such as AI data center thermal management and industrial water reuse.78
Investors should trim existing holdings or maintain an underweight allocation of 0-1% within diversified industrial portfolios.4
Risk management mandates strict exposure limits and disciplined portfolio trimming under the Reduce house rating. Given that Xylem is currently priced at $102.53 against an intrinsic fair value midpoint of $90.73, portfolio managers should avoid building exposure. Position monitoring should focus on quarterly book-to-bill in Measurement & Control Solutions to detect whether customer-side electric metering delays are spreading into water metering. Furthermore, international revenue trends in China and Europe must be audited against the 30% contraction observed in Q2 to verify that international weakness does not derail operating cash conversion. Position risk should be managed via strict profit-taking and trailing stops to protect invested capital against valuation multiple mean-reversion.
With shares trading at $102.53 against an intrinsic fair value midpoint of $90.73, Xylem offers a negative margin of safety (-11.5% implied return).4
Full-year reported revenue growth is guided to approximately 2%, constrained by electric metering project deferrals and a 30% order drop in China. This limits near-term multiple re-rating and upward earnings revisions despite strong data center momentum.5
Existing shareholders with multi-year compounder mandates may hold core positions given Xylem's narrow economic moat (score 7.5), defensive municipal water utility installed base, and steady free cash flow conversion ($910,000,000 in FY2025), while trimming tactical exposure.68
We recommend investors Reduce exposure to Xylem Inc. at the share price of $102.53 as of October 7, 2026. Our intrinsic fair value is $90.73 per share, indicating an implied return of -11.5%.4
Although Xylem commands an established municipal installed base and benefits from AI data center liquid cooling growth (~200% growth in FY2026), trading at 17.4x forward earnings and a 13.0% premium to fair value leaves an insufficient buffer against electric smart metering deferrals and regional industrial softness in China.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
In the bear scenario, protracted municipal budget constraints and prolonged electric metering project deferrals within Measurement & Control Solutions curtail organic revenue growth toward stagnation. Severe 30% order contractions in China spread to European commercial construction, while raw material cost inflation compresses operating margins toward 10.54%. Peer multiple de-rating pushes equity valuation toward the downside fair value boundary of $80.29.
Consensus projects revenue growing from $9,035,000,000 in FY2025 to $9,620,179,580 in FY2027 (~3.2% CAGR). With MCS book-to-bill falling below 1.0 and Asia-Pacific revenue down 30%, a 500 bps multi-year revenue growth shock triggers cumulative top-line stagnation.157
The base valuation assumes a terminal multiple of 17.0x, premium to peer CMI at 15.14x. If peer comparison exposes that XYL's operating margin (13.54%) significantly trails DOV (18.69%) and IR (16.88%), market multiple re-rates downward by 20% to 13.6x.347
Signals severe municipal utility budget contraction and cost inflation that eliminate productivity gains and compress operating earnings toward downside stress levels.
Huidig:13.54% (FY2025)
Waarschuwing als< 10.54%
Indicates deepening structural capital reallocation by Chinese authorities away from municipal civil infrastructure, impairing international revenue diversification.
Huidig:-30% YoY (Q2 2026)
Waarschuwing als< -35% YoY
Reveals erosion of pricing discipline against diversified peers Dover and Ingersoll Rand or unabsorbed factory overhead from 80/20 product walkaway.
Huidig:38.46% (FY2025)
Waarschuwing als< 37.00%
Triggers pillar falsification for the platform water moat, indicating that municipal replacement demand is stalling and switching costs are failing to protect core volume.
Huidig:2.24% projected for FY2026
Waarschuwing als<= 0.0% for two consecutive quarters
| Regional Infrastructure Contraction in China and Soft European Construction | medium | 12 to 24 months | Geographic diversification across more than 150 countries, robust U.S. municipal infrastructure funding, and high-growth industrial verticals like data center liquid cooling (~200% growth in FY2026) compensate for regional international softness.5 |
| Margin Superiority and Price Competition from Industrial Fluid Peers | low | 18 to 36 months | Ongoing implementation of 80/20 operational disciplines and synergy capture from the Evoqua integration drive structural cost reductions, supporting guided operating margin expansion toward 15.58% by FY2030.5 |
Under the moderate discount rate, US$ 21,74 comes from forecast-period earnings and US$ 78,00 from the long-term value, totaling US$ 99,74.
Project EPS through the explicit advantage period, fade growth as competition catches up, and discount the full stream at cost of equity.
Apply a terminal P/E to the dated forward EPS path, then discount that future share value back to the analysis date.
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and terminal value at WACC, then adjust for signed net debt per current share.
Discounted forecast-period cash flows (US$ 15,67) plus discounted terminal value (US$ 49,17) minus signed per current share (US$ 2,03) equals the US$ 62,81 lens value shown above. Negative net debt is , so subtracting it raises value.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Solve for the growth rate that makes the model value equal the report-date share price.
Multiply the peer median PEG by this stock's forecast growth to derive an implied forward P/E, then apply it to forward EPS.
In the bull scenario, accelerating adoption of AI data center liquid cooling systems and advanced industrial wastewater reuse drives multi-year organic revenue growth above 6%. Concurrently, rapid resolution of customer electric metering installation delays and enhanced 80/20 commercial execution unlock over 150 basis points of operating margin expansion, pushing operating margins toward 16.5%. Free cash flow conversion exceeds 100% of net income, supporting intrinsic valuation at the high end of the committee range ($102.86).
Represents the single largest geographic drag on Water Infrastructure and Applied Water, testing the limits of geographical diversification.5
Ensures manufacturing fulfillment continuity while verifying that inventory holding costs do not penalize operating cash flow or return on invested capital.5
| $10.19B |
| $10.67B |
| $11.12B |
| Revenue growth | 2.2% | 4.9% | 5.2% | 4.7% | 4.2% |
| Operating margin | 14.0% | 14.5% | 15.0% | 15.4% | 15.6% |
| Operating income | $1.29B | $1.41B | $1.53B | $1.64B | $1.73B |
| Tax rate | 18.1% | 18.1% | 18.1% | 18.1% | 18.1% |
| NOPAT | $1.06B | $1.15B | $1.25B | $1.34B | $1.42B |
| Reinvestment | $190.20M | $230.91M | $275.60M | $295.14M | $283.56M |
| Reinvestment rate (of NOPAT) | 18.0% | 20.0% | 22.0% | 22.0% | 20.0% |
| Free cash flow to firm | $866.47M | $923.65M | $977.14M | $1.05B | $1.13B |
| Water Infrastructure revenue | $2.70B | $2.83B | $2.97B | $3.11B | $3.24B |
| Water Solutions Services revenue | $2.52B | $2.64B | $2.78B | $2.91B | $3.03B |
| Measurementand Control Solutions revenue | $2.13B | $2.24B | $2.35B | $2.46B | $2.57B |
| Applied Water revenue | $1.89B | $1.98B | $2.09B | $2.18B | $2.27B |
| Terminal growth | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
Capital allocation remains conservative, value-accretive, and disciplined. Xylem maintains an investment-grade balance sheet with total debt of $3,055,000,064 and current liabilities of $2,856,000,000, resulting in a modest debt-to-capital weight of 11.32%. Capital expenditures of $331,000,000 in FY2025 represent a capital intensity of only 3.66% of sales, allowing management to return cash through regular dividends ($1.72 per share annual rate) while self-funding bolt-on acquisitions like WaterFleet. Reinvestment rates pacing between 18.0% and 22.0% of NOPAT adequately cover maintenance capex and buffer inventory investments without compromising shareholder returns.
XYL FY2025 gross profit of $3,475,000,000 on revenue of $9,035,000,000 represents a gross margin of 38.46%, comfortably above peer CMI at 25.77% and industry average gross margin of 37.50%, but trailing high-margin fluid peers DOV (40.09%) and IR (42.82%).
Confirms Xylem's pricing power and differentiation over heavy machinery manufacturers, while setting an upper boundary on valuation multiples relative to premium fluid engineering peers.
FY2025 operating income (EBIT) was $1,223,000,000 (13.54% margin), and management raised full-year 2026 operating margin expansion guidance to 90 to 130 basis points.
Productivity gains and 80/20 portfolio optimization generate structural margin expansion, supporting an operating margin progression toward 15.58% by FY2030 even during flat revenue quarters.
Operating cash flow reached $1,241,000,000 in FY2025 against net income of $957,000,000, while capex was limited to $331,000,000.
Robust cash generation supports low-double-digit free cash flow margins and allows self-funding of strategic buffer inventories without increasing financial leverage.
| Marge |
|---|
| XYL | Xylem Inc. | $23.9B | 17.4x | 2.6x | 13.4x | 9.2% | — |
| DOV | Dover Corporation | $25.4B | 16.2x | 3.0x | 14.3x | 14.9% | 18.7% |
| IR | Ingersoll Rand Inc. | $30.1B | 19.8x | 3.8x | 17.1x | 9.5% | 16.9% |
| CMI | Cummins Inc. | $72.2B | 15.1x | 2.1x | 15.4x | 21.1% | 11.9% |
| GNRC | Generac Holdings Inc. | $12.7B | 16.7x | 2.9x | 21.7x | 9.5% | 17.9% |
| Industrial Water Circularity and Wastewater Reuse | positive | Stricter environmental regulations and industrial water scarcity compel advanced manufacturing facilities, such as semiconductor fabs and lithium-ion battery plants, to install on-site outsourced water recycling solutions. |
| Regional Public Infrastructure Spending Reallocation in China | negative | Government capital reallocation away from traditional municipal civil works toward other industrial priorities in China created a 30% contraction in orders and revenue in Q2 2026, posing an ongoing regional headwind. |
| < $9,100,000,000 for FY2026 |
| Re-evaluate revenue loss from 80/20 product walkaway and reduce terminal multiple assumptions toward peer CMI levels (15.14x).3 |
| Consolidated EBIT Operating Margin | < 13.50% in any reported quarter | 7 |
